PUBLICATIONS

PL

No. AR PL HD Year Citation Title 1st author
84 X 2021 J Functional Foods 80, 104438(2021) Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro B Lis
83 X 2021 Int J Mol Sci 22(6):3282(2021) Anti-Platelet Properties of Phenolic and Nonpolar Fractions Isolated from Various Organs of Elaeagnus rhamnoides (L.) A. Nelson in Whole Blood B Skalski
82 X 2021 Biomed Pharmacother 137, 111395(2021) Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson M Juszczak
79 X 2021 Platelets 1-5(2021) The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions KL Zheng
78 X 2021 Thromb Haemost Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study S Ghirardello
72 X X 2020 Pol Arch Intern Med 130(12),p1114-1117(2020) Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome? K Ożegowska
71 X 2020 J Clin Med 9(8):2636(2020) Advances in Platelet Function Testing-Light Transmission Aggregometry and Beyond JL Blanc
69 X X 2020 Pediatr Int (2020) A microchip flow-chamber assay screens congenital primary hemostasis disorders Y Nakajima
67 X X 2020 Kardiol Pol 78(7-8),p667-673(2020) New methodological approaches for assessing thrombus formation in cardiovascular disease K Hosokawa
66 X 2020 J Pediatr S0022-3476(20),p30726-30735(2020) Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease N Tsujii
65 X 2020 Br J Haematol 191(1), e7-e10(2020) Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects J Charpy
62 X X 2020 Front Vet Sci 7:307(2020) A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis T Iwanaga
60 X X 2020 Circ J 84(6),p975-984(2020) Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention S Kikuchi
59 X 2019 Haematologica 235549(2019) Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab K Sakai
58 X X 2019 Int J Hematol 111, p369-377(2020) Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system Y Nakajima
57 X X 2019 J Atheroscler Thromb 27(3),p201-203(2020) Monitoring of Antithrombotic Therapy M Yamazaki
56 X X 2019 Thromb J 17, 17 (2019) Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study observational study K Yamamoto
55 X X 2019 J Atheroscler Thromb 27,p215-225(2020) Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease T Mitsuse
54 X X 2019 Thromb Haemost 119,p1554-1562(2019) Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease K Kaikita
53 X X 2019 Sci Rep 9:6573(2019) Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis MM Piasecka
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.